BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28258962)

  • 1. Renal Cell Carcinoma With Pulmonary Metastasis and Metachronous Non-Small Cell Lung Cancer.
    Bowman IA; Pedrosa I; Kapur P; Brugarolas J
    Clin Genitourin Cancer; 2017 Aug; 15(4):e675-e680. PubMed ID: 28258962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
    Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
    Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The option value of innovative treatments for non-small cell lung cancer and renal cell carcinoma.
    Thornton Snider J; Batt K; Wu Y; Tebeka MG; Seabury S
    Am J Manag Care; 2017 Oct; 23(10):e340-e346. PubMed ID: 29087638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary lesion after surgery for renal cancer: progression or new primary?
    Cignoli D; Bandiera A; Rosiello G; Castorina R; Re C; Cei F; Musso G; Belladelli F; Freschi M; Lucianò R; Raggi D; Negri G; Necchi A; Salonia A; Montorsi F; Larcher A; Capitanio U
    World J Urol; 2024 May; 42(1):361. PubMed ID: 38814376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary metastasis from renal cell carcinoma: characterization using contrast-enhanced CT attenuation value measurements.
    Jung DC; Choi HJ; Kim HY; Lee KH
    J Comput Assist Tomogr; 2009; 33(1):54-7. PubMed ID: 19188785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
    Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.
    de Gramont A; Van Cutsem E
    Oncology; 2005; 69 Suppl 3():46-56. PubMed ID: 16301835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
    Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
    Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-to-tumor metastases: papillary thyroid carcinoma into a clear cell renal cell carcinoma.
    Song JS; Taylor SM; Trites J; Rigby MH; Bullock MJ; Merrimen J; Rendon R; Hart RD
    J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):17. PubMed ID: 28249616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ
    Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography in metastatic renal cell carcinoma.
    Griffin N; Grant LA; Bharwani N; Sohaib SA
    Semin Ultrasound CT MR; 2009 Aug; 30(4):359-66. PubMed ID: 19711646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival.
    Duchateau CS; Stokkel MP
    Chest; 2005 Apr; 127(4):1152-8. PubMed ID: 15821189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α.
    Tsimafeyeu I; Zart JS; Chung B
    BJU Int; 2013 Jul; 112(1):32-8. PubMed ID: 23746142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral Asynchronous Renal Cell Carcinoma With Lung Metastases: A Case Report of a Patient Treated Solely With High-dose Intravenous and Subcutaneous
    Reynel M; Villegas Y; Kiene H; Werthmann PG; Kienle GS
    Anticancer Res; 2019 Oct; 39(10):5597-5604. PubMed ID: 31570455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of 42 Renal Cell Carcinoma Patients With Metastases Solely to the Lung Who Received Sorafenib as Second-line Systemic Therapy.
    Miyake H; Matsushita Y; Watanabe H; Tamura K; Motoyama D; Ito T; Sugiyama T; Otsuka A
    Anticancer Res; 2019 Feb; 39(2):1067-1072. PubMed ID: 30711996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
    de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
    Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.